The global biotechnology and pharmaceutical sectors are under immense pressure to accelerate drug development and reduce costs while ensuring product quality. Regulatory bodies increasingly emphasize cell viability and purity for clinical applications, driving demand for advanced separation techniques. Furthermore, a growing skilled labor deficit in research necessitates automated or simplified processes. This technology offers a strategic advantage by meeting these critical market needs, enabling faster R&D and higher quality outputs.
Achieves highly selective and efficient adsorption separation of target cells by precisely controlling intermediate water content. This method minimizes cell damage compared to conventional separation techniques, yielding cells with high purity and viability.
Simplifies the process by requiring only contact between the hydratable composition and the solution, eliminating the need for specialized equipment. This could significantly reduce implementation and operational costs by removing the need for expert skills.
Optimizes composition design for various cell types, including cancer cells, stem cells, and microorganisms. This offers high versatility for applications ranging from regenerative medicine to food inspection.
This patent protects a cell separation method and the hydratable composition itself, specifically defined by an intermediate water content of 30wt% or less. The claims are broad, covering both the process and the key material. The patent underwent rigorous examination, overcoming multiple rejections, which indicates strong novelty and inventiveness, providing robust protection against invalidation.
This patent focuses on the composition and method for cell separation. White space exists in developing integrated automated systems for high-throughput cell sorting or novel downstream applications for the separated cells, such as advanced cell culture substrates or diagnostic platforms.
In regenerative medicine research facilities, assuming annual operational costs (labor, reagents, equipment maintenance) of ~$650K (AI est.) for cell separation using conventional methods. This technology could reduce labor costs by 20% and reagent consumption by 15% due to simplified operations and improved efficiency. Additionally, a 5% reduction in opportunity cost is estimated from shortened research periods due to faster separation processes. This projects a direct and indirect cost reduction of ~$250K/year (AI est.) per facility.
X: Automation & Simplicity of Cell Separation
Y: Target Cell Purity & Viability